معرفی
Selena Peng is a Research Fellow in Drug Discovery Biology at Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences. Her research focuses on molecular pharmacology and disease mechanisms, particularly in metabolic and cardiovascular disorders.
Her primary research interests include:
- Pharmacology of G protein-coupled receptors
- Drug discovery for metabolic diseases
- Mechanisms of non-alcoholic steatohepatitis (NASH)
- Diabetic cardiomyopathy and cardiac dysfunction
- Preclinical modeling of chronic diseases
- Biased receptor signaling and trafficking
The recent publications by Selena Peng span from 2019 to 2024 and reflect a strong focus on molecular mechanisms underlying cardiometabolic diseases. Her work integrates pharmacological, cellular, and in vivo approaches, with emphasis on receptor dynamics and therapeutic modeling. Key themes include receptor signaling bias, liver disease pathology, and cardiac complications of diabetes.
No scientific awards are currently listed.
Selena Peng collaborates with senior researchers including Prof. Ritchie H. Ritchie and Dr. Qin C. X., contributing to funded research projects in cardiometabolic pharmacology. While no direct mention of grants or student supervision is made, her role as a Research Fellow and co-author on multiple peer-reviewed studies indicates active participation in a larger research team. She is likely involved in both experimental design and data analysis within her group.
She is part of the Drug Discovery Biology research theme at Monash Institute of Pharmaceutical Sciences, which focuses on identifying and validating novel therapeutic targets and developing new pharmacological agents for chronic diseases.
